Loading...
Loading...
CVS Health Corp CVS boosted its 2021 guidance ahead of its fourth-quarter earnings in early February, with executives citing better-than-expected performance in its retail segment.
- In an SEC filing, the Company raised its full-year earnings projections to $8.33 - $8.38 per share from a previous estimate of $8.
- The Company also affirmed its 2022 guidance of $8.10 - $8.30 per share.
- Related: CVS Plans 900 Store Closures Over Three Years.
- During the annual J.P. Morgan Healthcare Conference, CVS's chief financial officer, Shawn Guertin, said the retail business's strong results in the fourth quarter account for about 80% of the overperformance CVS saw.
- See the Company presentation here.
- As COVID-19 pandemic response, the Company administered around 59 million vaccines and about 32 million tests.
- Price Action: CVS shares are up 0.85% at $105.95 during the market session on the last check Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in